Carcinogenesis Advance Access published online on January 7, 2006
Carcinogenesis, doi:10.1093/carcin/bgi338
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome, Italy
* To whom correspondence should be addressed. The present study was designed to investigate the effects of a phytoestrogens-containing soy extract (SOYSELECT®, SSE) on the growth of estrogen-dependent (MCF-7) and estrogen-unresponsive (MDA-MB-231) human breast cancer xenografts in athymic mice. Results obtained provided evidence that MCF-7 tumors did not grow over the treatment period (five weeks) in ovariectomized females receiving 50 or 100 mg/kg/day SSE (oral route); administration of SSE also did not affect the estradiol-sustained growth of MCF-7 tumors in mice. Similarly, no effects on tumor growth were observed in SSE-treated mice bearing MDA-MB-231 xenografts. Data from pS2, progesterone receptor, and cyclin D1 mRNA expression in tumors showed that, although SSE was able to induce a moderate estrogenic effect in MCF-7 cells, it did not increase cellular proliferation and tumor growth, in our experimental conditions. Besides, when used in association with 17
Received September 6, 2005
Revised December 9, 2005
Accepted January 3, 2006
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION
Lack of stimulatory activity of a phytoestrogen-containing soy extract on the growth of breast cancer tumors in mice
Daniela Gallo 1 *,
Cristiano Ferlini 1,
Manuela Fabrizi 1,
Silvia Prislei 1,
and
Giovanni Scambia 2
2 Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome, Italy; Department of Oncology, Catholic University of the Sacred Heart, Campobasso, Italy
Daniela Gallo, E-mail: d.gallo{at}rm.unicatt.it
Abstract 
-estradiol, it displayed antiestrogenic activity. The expression of other genes involved in tumor progression and angiogenesis, such as Thrombospondin 1, Trasforming Growth Factor 2, and Kallikrein 6 was also evaluated in tumor samples, results showing a decrease in mRNA expression upon SSE treatment. The effect of SSE on angiogenesis in vivo was also evaluated in the Matrigel plug assay; results obtained showed a striking anti-angiogenic activity in mice receiving 100 mg/kg/day SSE, thereby confirming that this extract may interfere with angiogenesis. Collectively, these experimental data suggest that SSE could be not harmful for women with a history of or at high risk for breast cancer, at least for short treatment-periods; however, further studies are needed to thoroughly characterize the activity profile of the extract in this specific setting of patients.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Gallo, G. F. Zannoni, I. De Stefano, M. Mosca, C. Ferlini, E. Mantuano, and G. Scambia Soy Phytochemicals Decrease Nonsmall Cell Lung Cancer Growth In Female Athymic Mice J. Nutr., July 1, 2008; 138(7): 1360 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gallo, E. Mantuano, M. Fabrizi, C. Ferlini, S. Mozzetti, I. De Stefano, and G. Scambia Effects of a phytoestrogen-containing soy extract on the growth-inhibitory activity of ICI 182 780 in an experimental model of estrogen-dependent breast cancer Endocr. Relat. Cancer, June 1, 2007; 14(2): 317 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rice and S. A Whitehead Phytoestrogens and breast cancer -promoters or protectors? Endocr. Relat. Cancer, December 1, 2006; 13(4): 995 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Messina, W. McCaskill-Stevens, and J. W. Lampe Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst, September 20, 2006; 98(18): 1275 - 1284. [Abstract] [Full Text] [PDF]
|
|